These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16518407)
1. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Arnesen T; Gromyko D; Pendino F; Ryningen A; Varhaug JE; Lillehaug JR Oncogene; 2006 Jul; 25(31):4350-60. PubMed ID: 16518407 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Arnesen T; Anderson D; Baldersheim C; Lanotte M; Varhaug JE; Lillehaug JR Biochem J; 2005 Mar; 386(Pt 3):433-43. PubMed ID: 15496142 [TBL] [Abstract][Full Text] [Related]
3. Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase. Arnesen T; Betts MJ; Pendino F; Liberles DA; Anderson D; Caro J; Kong X; Varhaug JE; Lillehaug JR BMC Biochem; 2006 Apr; 7():13. PubMed ID: 16638120 [TBL] [Abstract][Full Text] [Related]
4. The protein acetyltransferase ARD1: a novel cancer drug target? Arnesen T; Thompson PR; Varhaug JE; Lillehaug JR Curr Cancer Drug Targets; 2008 Nov; 8(7):545-53. PubMed ID: 18991565 [TBL] [Abstract][Full Text] [Related]
5. Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms. Arnesen T; Gromyko D; Horvli O; Fluge Ø; Lillehaug J; Varhaug JE Thyroid; 2005 Oct; 15(10):1131-6. PubMed ID: 16279846 [TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of hNAT5/hSAN: an evolutionarily conserved component of the NatA protein N-alpha-acetyltransferase complex. Arnesen T; Anderson D; Torsvik J; Halseth HB; Varhaug JE; Lillehaug JR Gene; 2006 Apr; 371(2):291-5. PubMed ID: 16507339 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Lysine Acetyltransferase Activity of Recombinant Human ARD1/NAA10. Vo TTL; Park JH; Lee EJ; Nguyen YTK; Han BW; Nguyen HTT; Mun KC; Ha E; Kwon TK; Kim KW; Jeong CH; Seo JH Molecules; 2020 Jan; 25(3):. PubMed ID: 32013195 [TBL] [Abstract][Full Text] [Related]
8. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Lim JH; Park JW; Chun YS Cancer Res; 2006 Nov; 66(22):10677-82. PubMed ID: 17108104 [TBL] [Abstract][Full Text] [Related]
9. The chaperone-like protein HYPK acts together with NatA in cotranslational N-terminal acetylation and prevention of Huntingtin aggregation. Arnesen T; Starheim KK; Van Damme P; Evjenth R; Dinh H; Betts MJ; Ryningen A; Vandekerckhove J; Gevaert K; Anderson D Mol Cell Biol; 2010 Apr; 30(8):1898-909. PubMed ID: 20154145 [TBL] [Abstract][Full Text] [Related]
10. Proteome-derived peptide libraries allow detailed analysis of the substrate specificities of N(alpha)-acetyltransferases and point to hNaa10p as the post-translational actin N(alpha)-acetyltransferase. Van Damme P; Evjenth R; Foyn H; Demeyer K; De Bock PJ; Lillehaug JR; Vandekerckhove J; Arnesen T; Gevaert K Mol Cell Proteomics; 2011 May; 10(5):M110.004580. PubMed ID: 21383206 [TBL] [Abstract][Full Text] [Related]
11. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1). Arnesen T; Gromyko D; Kagabo D; Betts MJ; Starheim KK; Varhaug JE; Anderson D; Lillehaug JR BMC Biochem; 2009 May; 10():15. PubMed ID: 19480662 [TBL] [Abstract][Full Text] [Related]
12. Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro. Murray-Rust TA; Oldham NJ; Hewitson KS; Schofield CJ FEBS Lett; 2006 Apr; 580(8):1911-8. PubMed ID: 16500650 [TBL] [Abstract][Full Text] [Related]
13. Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Seo JH; Cha JH; Park JH; Jeong CH; Park ZY; Lee HS; Oh SH; Kang JH; Suh SW; Kim KH; Ha JY; Han SH; Kim SH; Lee JW; Park JA; Jeong JW; Lee KJ; Oh GT; Lee MN; Kwon SW; Lee SK; Chun KH; Lee SJ; Kim KW Cancer Res; 2010 Jun; 70(11):4422-32. PubMed ID: 20501853 [TBL] [Abstract][Full Text] [Related]
14. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Arnesen T; Van Damme P; Polevoda B; Helsens K; Evjenth R; Colaert N; Varhaug JE; Vandekerckhove J; Lillehaug JR; Sherman F; Gevaert K Proc Natl Acad Sci U S A; 2009 May; 106(20):8157-62. PubMed ID: 19420222 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin. Lim JH; Chun YS; Park JW Cancer Res; 2008 Jul; 68(13):5177-84. PubMed ID: 18593917 [TBL] [Abstract][Full Text] [Related]
16. Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha. Arnesen T; Kong X; Evjenth R; Gromyko D; Varhaug JE; Lin Z; Sang N; Caro J; Lillehaug JR FEBS Lett; 2005 Nov; 579(28):6428-32. PubMed ID: 16288748 [TBL] [Abstract][Full Text] [Related]
17. Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer. Yu M; Ma M; Huang C; Yang H; Lai J; Yan S; Li L; Xiang M; Tan D Cancer Invest; 2009 Dec; 27(10):978-83. PubMed ID: 19909012 [TBL] [Abstract][Full Text] [Related]
18. Characterization of ARD1 variants in mammalian cells. Kim SH; Park JA; Kim JH; Lee JW; Seo JH; Jung BK; Chun KH; Jeong JW; Bae MK; Kim KW Biochem Biophys Res Commun; 2006 Feb; 340(2):422-7. PubMed ID: 16376303 [TBL] [Abstract][Full Text] [Related]
19. [hARD1 antiserum preparation and primary immunohistochemical analysis of hARD1 in tumor tissues]. Yu M; Huang C; Xiang M; Lai J; Yang H; Ma M; Tan D Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1155-61. PubMed ID: 18837388 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1. Sánchez-Puig N; Fersht AR Protein Sci; 2006 Aug; 15(8):1968-76. PubMed ID: 16823041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]